Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells

This publication has 51 references indexed in Scilit:

• N‐myc downstream regulated gene 1 modulates Wnt‐β‐catenin signalling and pleiotropically suppresses metastasis
  EMBO Molecular Medicine, 2012
• Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo
  FEBS Letters, 2011
• Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
  Proceedings of the National Academy of Sciences, 2011
• Silibinin Exerts Sustained Growth Suppressive Effect against Human Colon Carcinoma SW480 Xenograft by Targeting Multiple Signaling Molecules
  Pharmaceutical Research, 2010
• Mesd Is a Universal Inhibitor of Wnt Coreceptors LRP5 and LRP6 and Blocks Wnt/β-Catenin Signaling in Cancer Cells
  Biochemistry, 2010
• LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
  Proceedings of the National Academy of Sciences, 2010
• Chemoprevention of Intestinal Tumorigenesis in APCmin/+ Mice by Silibinin
  Cancer Research, 2010
• Silibinin Suppresses Spontaneous Tumorigenesis in APC min/+ Mouse Model by Modulating Beta-Catenin Pathway
  Pharmaceutical Research, 2009
• Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
  Developmental Cell, 2009
• Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
  European Journal of Pharmacology, 2009